Long-chain 3 hydroxyacylCoA Dehydrogenase (LCHAD) Deficiency

Explore clinical trials studying Long-chain 3 hydroxyacylCoA Dehydrogenase (LCHAD) Deficiency. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Long-chain 3 hydroxyacylCoA Dehydrogenase (LCHAD) Deficiency trial results

Completed

Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder

NCT01379625

Conditions: Carnitine Palmitoyltransferase 2 (CPT2) Deficiency, Long-chain 3 hydroxyacylCoA Dehydrogenase (LCHAD) Deficiency, Mitochondrial Trifunctional Protein (TFP) Deficiency, +2 more
Locations: Oregon Health & Science University Portland, Oregon, United States

University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Carnitine Palmitoyltransferase 2 (CPT2) Deficiency (1)
Mitochondrial Trifunctional Protein (TFP) Deficiency (1)
Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency (1)
VLCAD deficiency (1)

Long-chain 3 hydroxyacylCoA Dehydrogenase (LCHAD) Deficiency

Long-chain 3 hydroxyacylCoA Dehydrogenase (LCHAD) Deficiency trial results

Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder

Related conditions